(University of Pennsylvania School of Medicine) Promising, early studies of deep brain stimulation (DBS) for the treatment of Alzheimer's disease have paved a path for future clinical trials, but there are unique ethical challenges with this vulnerable population regarding decision making and post-study treatment access that need to be addressed as they ramp up, Penn Medicine researchers argue in a new review in the Journal of Alzheimer's Disease.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2jVMVt0
No comments:
Post a Comment